Renda Li

机构：Chinese Academy of Medical Sciences & Peking Union Medical College, Shanghai Institute of Materia Medica, Northeastern University · ORCID：0000-0003-3117-5762

发表论文 42 篇 · 总被引 1108 次 · h-index 18

代表论文

• A non‐metabolic function of hexokinase 2 in small cell lung cancer: promotes cancer cell stemness by increasing USP11‐mediated CD133 stability (2022 · 癌症：英文版 · 被引 90)
• Whole‐genome bisulfite sequencing analysis of circulating tumour DNA for the detection and molecular classification of cancer (2022 · Clinical and Translational Medicine · 被引 52)
• Treatment patterns and clinical outcomes of patients with resectable non–small cell lung cancer receiving neoadjuvant immunochemotherapy: A large-scale, multicenter, real-world study (NeoR-World) (2024 · Journal of Thoracic and Cardiovascular Surgery · 被引 32)
• The Deubiquitinase USP13 Maintains Cancer Cell Stemness by Promoting FASN Stability in Small Cell Lung Cancer (2022 · Frontiers in Oncology · 被引 23)
• Development of a Novel HER2-Targeted Peptide Probe for Dual-Modal Imaging of Tumors (2023 · Journal of Medicinal Chemistry · 被引 22)
• Fibroblast Activation Protein Targeting Probe with Gly–Pro Sequence for PET of Glioblastoma (2023 · Molecular Pharmaceutics · 被引 21)